Mixed Reality in Healthcare Market Trends, Growth and Size Analysis By Component (Software, Hardware, Service), Device Type (Augmented Reality in Healthcare, Virtual Reality in Healthcare), Application (Surgery Simulation, Surgery, Patient Care Management, Pharmacy Management, Fitness Management, Others), End User (Hospital & Surgical Centers, Pharmaceutical Companies, Research Organizations, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2032

Mixed Reality Healthcare Market Summary

As per Market Research Future Analysis, the Mixed Reality in Healthcare Market was valued at USD 2.77 Billion in 2023 and is projected to grow to USD 6.14 Billion by 2032, with a CAGR of 9.27% from 2024 to 2032. The market is driven by advancements in sensor technology, increased user acceptance, and the growing application of MR in treatment and training. Key applications include surgery simulation and patient care management, with hospitals and surgical centers being the primary end users. However, challenges such as high investment costs and technical issues may hinder growth. Strategic partnerships and regulatory changes are expected to mitigate these barriers.

Key Market Trends & Highlights

Key trends influencing the Mixed Reality in Healthcare Market include technological advancements and strategic collaborations.

• Market Size in 2023: USD 2.77 Billion
• Projected Market Size by 2032: USD 6.14 Billion
• CAGR from 2024 to 2032: 9.27%
• Major applications include surgery simulation and patient care management.

Market Size & Forecast

2023 Market Size: USD 2.77 Billion

2024 Market Size: USD 3.02 Billion

2032 Market Size: USD 6.14 Billion

CAGR (2024-2032): 9.27%

Major Players

Atheer, Augmedix, Daqri, Echopixel, Firsthand Technology, Google Medical Realities, Microsoft, Mindmaze, Oculus VR, Orca Health, Osso VR, Psious, Samsung Electronics, Surgical Theatre LLC

Mixed Reality in Healthcare Market Scenario

Mixed Reality in Healthcare Market Size was valued at USD 2.77 Billion in 2023. The Mixed Reality in Healthcare industry is projected to grow from USD 3.02 Billion in 2024 to USD 6.14 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.27% during the forecast period (2024 - 2032).

Healthcare Mixed Reality (MR) is an amalgamation of Augmented Reality (AR) and Virtual Reality (VR), defining the polar ends of a spectrum known as vitality spectrum or mixed reality spectrum. Augmented reality delivers digital components, whereas virtual reality enables immersive imitation of real-life settings. MR has widespread applications in different fields of healthcare, varying from treatment to training and education.

The global market of healthcare mixed reality is fueled by factors such as rapid improvements in the adoption of sensor technology, increase in the user acceptance, increased applications of MR in disease care and treatment, and increasing workload of healthcare professionals. Additionally, the benefits of MR systems such as operational efficiency, increased service quality, and reduced human effort is also projected to drive the growth of the mixed reality in healthcare market. For instance, in 2018, Samsung completed a randomized control trial that showed that VR therapy reduces pain by 52%.

On the other hand, the lack of adequate skill among medical practitioners, high investment costs, occurrences of technical glitches and the concern related to loss of data is likely to curb the growth of the market during the assessment period. Nevertheless, changes in regulatory policies are expected to reduce the impact of barriers over the forecast period.

Moreover, major companies in the market are involved in strategic acquisitions and collaborations to brace their position in the market. For instance, in March 2018, Samsung announced a partnership with Travelers Insurance, Cedars-Sinai Medical Center, Bayer, and AppliedVR to study a virtual reality for pain management.

Rapid advances in sensor technology, rising user acceptability, expanding uses of MR in illness care and treatment, and rising healthcare professionals' workloads all contribute to the growth of the worldwide mixed reality in healthcare market. The advantages of MR systems, such improved productivity, higher service quality, and less need for human intervention, are also expected to fuel the healthcare MR market's expansion.

July 2023: Innovate UK has given funds to FourPlus, a UK immersive technology firm, Holosphere, and the Cell and Gene Therapy Catapult to develop and pilot a mixed-reality training platform for the pharmaceutical and healthcare industries beginning in July 2023. Investment of $1 million has been made in the project through the digitalization and automation of pharmaceuticals R&D and manufacturing competition, with around 75% coming from Innovate UK. The money will go toward building a flexible platform with mixed reality and multiplayer capability.

There are a variety of manufacturing positions in the cell and gene therapy, biopharmaceutical, and broader life science industries, as well as in hospital settings, that will benefit from this digital and automated training platform.

Healthcare Mixed Reality Market Segmentation

The mixed reality in healthcare market has been segmented into component, device type, application, and end user.

The market, based on component, has been segmented into software, hardware, and service. The software segment is expected to hold a major share due to the increased accessibility of software to the users, whereas the hardware segment is projected to be the fastest growing segment owing to ease of availability of hardware components.

The market of mixed reality in healthcare, by device type, has been segmented into augmented reality in healthcare and virtual reality in healthcare. The AR in healthcare segment is expected to hold a major share due to the increased application of AR for the attenuation of pain perception, whereas VR in healthcare segment is anticipated to be the fastest growing segment owing to rise in awareness and increased research in this field. The market, by augmented reality in healthcare, has been further segmented into head-mounted display (HMD), and handheld device.

The market, by virtual reality in healthcare, has been segmented into head-mounted display (HMD), gesture tracking devices, projectors, and others.

The market of mixed reality in healthcare, by application, has been segmented into surgery simulation, surgery, patient care management, pharmacy care management, fitness management, and others. The surgery simulation segment is expected to hold a major share owing to the increasing use of MR tools for training surgeons due to the anatomically realistic recreations. The segment of surgery is expected to be the fastest growing segment due to the increased patient population in recent years.

The market, by end user, has been segmented into hospital and surgical centers, research organizations, and others. The segment of hospital and surgical centers is projected to hold a major share due to the rise in the hospitals switching to MR systems, whereas the segment of research organizations is expected to be the fastest growing segment due to the increased research initiatives.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The mixed reality in healthcare market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Key Players

• Atheer
• Augmedix
• Daqri
• Echopixel
• Firsthand Technology
• Google
• Medical Realities
• Microsoft
• Mindmaze
• Oculus VR
• Orca Health
• Osso VR
• Psious
• Samsung Electronics
• Surgical Theatre LLC

Mixed Reality Healthcare Market Industry Developments

• Q2 2024: Microsoft and Cleveland Clinic expand mixed reality partnership for surgical training Microsoft announced an expanded partnership with Cleveland Clinic to deploy HoloLens 2 mixed reality headsets for advanced surgical training and remote collaboration, aiming to enhance medical education and patient outcomes.
• Q2 2024: Philips launches new mixed reality platform for image-guided therapy Philips introduced a mixed reality solution integrating augmented reality visualization into its image-guided therapy systems, enabling clinicians to overlay 3D anatomical data during minimally invasive procedures.
• Q2 2024: Siemens Healthineers debuts mixed reality surgical navigation system Siemens Healthineers launched a new mixed reality surgical navigation platform designed to assist surgeons with real-time 3D visualization and intraoperative guidance, targeting complex orthopedic and neurosurgical procedures.
• Q3 2024: Magic Leap secures $150 million funding round to accelerate healthcare mixed reality solutions Magic Leap raised $150 million in a new funding round led by healthcare-focused investors, with proceeds earmarked for expanding its mixed reality platform for medical training, surgical planning, and patient care applications.
• Q3 2024: Medtronic acquires XRHealth’s healthcare mixed reality division Medtronic completed the acquisition of XRHealth’s healthcare-focused mixed reality business unit, aiming to integrate immersive technologies into its digital surgery and remote patient monitoring portfolios.
• Q3 2024: Osso VR partners with Johnson & Johnson for global rollout of mixed reality surgical training Osso VR announced a strategic partnership with Johnson & Johnson to deploy its mixed reality surgical training platform across J&J’s global network, supporting skill development for surgeons in multiple specialties.
• Q4 2024: FDA clears Augmedics’ xvision Spine System with mixed reality guidance for pediatric use The U.S. FDA granted clearance for Augmedics’ xvision Spine System, a mixed reality surgical guidance platform, to be used in pediatric spinal procedures, expanding its clinical indications.
• Q4 2024: Medivis launches new mixed reality platform for preoperative planning in neurosurgery Medivis unveiled a next-generation mixed reality platform designed to assist neurosurgeons with preoperative planning, offering immersive 3D visualization of patient anatomy and surgical pathways.
• Q1 2025: SentiAR raises $35 million Series C to expand mixed reality cardiac navigation SentiAR closed a $35 million Series C funding round to accelerate the commercialization of its mixed reality cardiac navigation system, which provides real-time 3D visualization for electrophysiology procedures.
• Q1 2025: FundamentalVR announces partnership with Mayo Clinic for mixed reality surgical simulation FundamentalVR entered a partnership with Mayo Clinic to co-develop mixed reality surgical simulation modules, aiming to enhance hands-on training for medical residents and practicing surgeons.
• Q2 2025: GE HealthCare opens new mixed reality innovation center in Boston GE HealthCare inaugurated a dedicated innovation center in Boston focused on developing and testing mixed reality solutions for clinical workflow optimization and medical education.
• Q2 2025: Apple receives CE mark for Vision Pro mixed reality headset in European healthcare Apple’s Vision Pro mixed reality headset received CE mark approval for use in European healthcare settings, enabling deployment in surgical planning, medical training, and patient engagement applications.

Regional Market Summary

Geographically, the Americas is expected to dominate the global mixed reality in healthcare market due to the increasing per capita healthcare expenditure, and the heavy adoption of new technology. According to the research published in 2016 by Johns Hopkins University School of Medicine, it was estimated that if all US hospitals increased the number of minimally invasive procedures by 50%, nearly 3,600 complications could be avoided annually. Furthermore, rising expenses in research and investment by healthcare bodies are anticipated to drive the growth of the market in this region.

Europe showed a considerable amount of growth in the global mixed reality in healthcare market. The market growth in this region is because of the presence of a well-established healthcare system and increase in chronic diseases.

Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool and government initiatives of healthcare reforms. In 2016, as a part of an ongoing neurosurgical collaboration between Children’s Hospital in Ho Chi Minh City (Vietnam) and Children’s of Alabama Hospital, a Virtual Interactive Presence and Augmented Reality (VIPAR) telecommunication system was implemented at both hospitals to provide intraoperative assistance to medical professionals. However, less capital investment is restricting the market growth of this region.

On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. Moreover, limited access to treatment facilities is also expected to curb the growth of the market in the near future.

By Component Outlook

• Software
• Hardware
• Service

By Device Type Outlook

• Augmented Reality in Healthcare
• Head-Mounted Display (HMD)
• Handheld Device
• Virtual Reality in Healthcare
• Head-Mounted Display (HMD)
• Gesture Tracking Devices
• Projectors

By Application Outlook

• Surgery Simulation
• Surgery
• Patient Care Management
• Pharmacy Management
• Fitness Management
• Others

By End User Outlook

• Hospital & Surgical Centers
• Research Organizations
• Others

By Region Outlook

• Americas
  • US
  • Canada
• North America
• Latin America

• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Rest of Western Europe
• Western Europe
• Eastern Europe

• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific

• Middle East & Africa
• Middle East
• Africa

Intended Audience

• Medical Device Companies
• Research and Development (R&D) Companies
• Government and Private Research Institutes
• Academic Institutes and Universities
• Venture Capitalists

Report Attribute/Metric	Details
Market Size 2023	USD 2.77 Billion
Market Size 2024	USD 3.02 Billion
Market Size 2032	USD 6.14 Billion
CAGR	9.27% (2024 - 2032)
Base Year	2023
Forecast Period	2024-2032
Historical Data	2021
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Component, Type, Application, End User, Region
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Mindmaze, Atheer, Augmedix, Firsthand Technology, Daqri, Medical Realities, Google, Microsoft, Echopixel, Oculus VR, Orca Health, Psious, Samsung Electronics, Surgical Theatre LLC, and Osso VR.
Key Market Opportunities	Increasing research & development investments by industry players
Key Market Drivers	·  Rapid improvements in the adoption of sensor technology·  Increase in the user acceptance·  Increasing workload of healthcare professionals